BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36594409)

  • 1. Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis.
    Muneeb Hassan M; Ameeq M; Jamal F; Tahir MH; Mendy JT
    Ann Med; 2023 Dec; 55(1):285-291. PubMed ID: 36594409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors identification of COVID-19 patients with chronic obstructive pulmonary disease: A retrospective study in Punjab-Pakistan.
    Hassan MM; Tahir MH; Ameeq M; Jamal F; Mendy JT; Chesneau C
    Immun Inflamm Dis; 2023 Aug; 11(8):e981. PubMed ID: 37647450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of severe coronavirus disease 2019 patients with chronic obstructive pulmonary disease.
    Liang H; Lu R; Li Y; Pan P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1695-1703. PubMed ID: 36748380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease.
    Andreen N; Andersson LM; Sundell N; Gustavsson L; Westin J
    Infect Dis (Lond); 2022 Jul; 54(7):508-513. PubMed ID: 35287524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of Chronic Obstructive Pulmonary Disease Attributable to Tuberculosis: A Microsimulation Study.
    Sy KTL; Horváth-Puhó E; Sørensen HT; Szépligeti SK; Heeren TC; Thomsen RW; Fox MP; Horsburgh CR
    Am J Epidemiol; 2023 Jun; 192(6):908-915. PubMed ID: 36813297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coinfection of COVID-19 and extrapulmonary tuberculosis].
    Velásquez Gortaire E; Sívori M; Jajati M; Trullás MF
    Medicina (B Aires); 2022; 82(2):167-171. PubMed ID: 35417378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Risk of Incident Chronic Obstructive Pulmonary Disease and Related Hospitalizations in Tuberculosis Survivors: A Population-Based Matched Cohort Study.
    Kim T; Choi H; Kim SH; Yang B; Han K; Jung JH; Kim BG; Park DW; Moon JY; Kim SH; Kim TH; Yoon HJ; Shin DW; Lee H
    J Korean Med Sci; 2024 Mar; 39(11):e105. PubMed ID: 38529575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19.
    Sy KTL; Haw NJL; Uy J
    Infect Dis (Lond); 2020; 52(12):902-907. PubMed ID: 32808838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study.
    Oh TK; Song IA
    BMC Pulm Med; 2021 Jan; 21(1):12. PubMed ID: 33407347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diseased lungs may hinder COVID-19 development: A possible reason for the low prevalence of COPD in COVID-19 patients.
    Yong SJ
    Med Hypotheses; 2021 Aug; 153():110628. PubMed ID: 34139599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
    Sheikh D; Tripathi N; Chandler TR; Furmanek S; Bordon J; Ramirez JA; Cavallazzi R
    Respir Med; 2022 Jan; 191():106714. PubMed ID: 34915396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Prognostic Metabolomic Biomarkers at the Interface of Mortality and Morbidity in Pre-Existing TB Cases Infected With SARS-CoV-2.
    Diboun I; Cyprian FS; Anwardeen NR; Yassine HM; Elrayess MA; Rahmoon SM; Sayed SK; Schuchardt S; Khatib M; Bansal D; Farag EABA; Emara MM; Abdallah AM
    Front Cell Infect Microbiol; 2022; 12():929689. PubMed ID: 35937683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Decline in COPD Admissions During the COVID-19 Pandemic Associated with Lower Burden of Community Respiratory Viral Infections.
    So JY; O'Hara NN; Kenaa B; Williams JG; deBorja CL; Slejko JF; Zafari Z; Sokolow M; Zimand P; Deming M; Marx J; Pollak AN; Reed RM
    Am J Med; 2021 Oct; 134(10):1252-1259.e3. PubMed ID: 34126098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COPD and the risk of tuberculosis--a population-based cohort study.
    Inghammar M; Ekbom A; Engström G; Ljungberg B; Romanus V; Löfdahl CG; Egesten A
    PLoS One; 2010 Apr; 5(4):e10138. PubMed ID: 20405056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry.
    De Luca G; Nardin M; Algowhary M; Uguz B; Oliveira DC; Ganyukov V; Zimbakov Z; Cercek M; Okkels Jensen L; Loh PH; Calmac L; Roura Ferrer G; Quadros A; Milewski M; Scotto di Uccio F; von Birgelen C; Versaci F; Ten Berg J; Casella G; Wong Sung Lung A; Kala P; Díez Gil JL; Carrillo X; Dirksen M; Becerra-Munoz VM; Lee MK; Arifa Juzar D; de Moura Joaquim R; Paladino R; Milicic D; Davlouros P; Bakraceski N; Zilio F; Donazzan L; Kraaijeveld A; Galasso G; Lux A; Marinucci L; Guiducci V; Menichelli M; Scoccia A; Yamac AH; Ugur Mert K; Flores Rios X; Kovarnik T; Kidawa M; Moreu J; Flavien V; Fabris E; Martínez-Luengas IL; Boccalatte M; Bosa Ojeda F; Arellano-Serrano C; Caiazzo G; Cirrincione G; Kao HL; Sanchis Forés J; Vignali L; Pereira H; Manzo S; Ordoñez S; Özkan AA; Scheller B; Lehtola H; Teles R; Mantis C; Antti Y; Brum Silveira JA; Zoni R; Bessonov I; Savonitto S; Kochiadakis G; Alexopoulos D; Uribe CE; Kanakakis J; Faurie B; Gabrielli G; Gutierrez Barrios A; Bachini JP; Rocha A; Tam FC; Rodriguez A; Lukito AA; Saint-Joy V; Pessah G; Tuccillo A; Cortese G; Parodi G; Bouraghda MA; Kedhi E; Lamelas P; Suryapranata H; Verdoia M
    Respir Res; 2022 Aug; 23(1):207. PubMed ID: 35971173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease.
    Myers LC; Murray R; Donato B; Liu VX; Kipnis P; Shaikh A; Franchino-Elder J
    Respir Med; 2023 Jan; 206():107064. PubMed ID: 36459955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of tuberculosis/COVID-19 co-infection and factors associated with SARS-CoV-2 infection in pulmonary tuberculosis patients at a respiratory diseases center: a cross-sectional study.
    Mangamba LE; Sike CIM; Tochie JN; Dalle GN; Nkouagmi N; Balkissou AD; Bille BE; Ngahane BHM; Moukoko CEE
    Pan Afr Med J; 2023; 44():204. PubMed ID: 37484595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
    Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of the COVID-19 epidemic on the course of the most common respiratory diseases].
    Bogos K; Berta J; Cselkó Z; Tisza J; Szilasi M; Simon B; Antus B; Vizi É; Megyesfalvi Z; Döme B; Rózsás A; Török S
    Orv Hetil; 2023 Jan; 164(2):51-56. PubMed ID: 36641759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study.
    Li G; Liu Y; Jing X; Wang Y; Miao M; Tao L; Zhou Z; Xie Y; Huang Y; Lei J; Gong G; Jin P; Hao Y; Faria NR; Clercq E; Zhang M
    Aging (Albany NY); 2020 Dec; 13(1):27-60. PubMed ID: 33472167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.